Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Xia Fang, Chao He, Xudong Ni, Tianli Zhang, Qianyu Li, Yi Luo, Wei Long & Rui Wu. (2022) A potential model of systemic sclerosis with pulmonary hypertension induced by monocrotaline plus bleomycin. Clinical and Experimental Hypertension 44:6, pages 507-513.
Read now
Read now
Articles from other publishers (5)
Jinzhi Lai, Jiuliang Zhao, Kaiwen Li, Xiaohan Qin, Hui Wang, Zhuang Tian, Qian Wang, Mengtao Li, Xiaoxiao Guo, Yongtai Liu & Xiaofeng Zeng. (2022) Right Ventricle to Pulmonary Artery Coupling Predicts the Risk Stratification in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Dina Fathy Elessawi, Hala Gabr, Monda Mohamed Maher Badawy & Tamer A. Gheita. (2021) Therapeutic potential of mesenchymal stem cells for scleroderma induced in mouse model. Tissue and Cell 73, pages 101671.
Crossref
Crossref
Shota Okamoto, Yuya Kondo, Kimi Sato, Taihei Nishiyama, Hirofumi Toko, Mizuki Yagishita, Masahiro Yokosawa, Hiroto Tsuboi, Masaki Ieda & Isao Matsumoto. (2021) Anti-PL-7 antibody positive antisynthetase syndrome diagnosed after the onset of pulmonary hypertension and right-sided heart failure. Rheumatology 60:8, pages e277-e279.
Crossref
Crossref
Zhixiao Xu, Jiaxing Ruan, Lingyun Pan & Chengshui Chen. (2021) Candidate Genes Identified in Systemic Sclerosis-Related Pulmonary Arterial Hypertension Were Associated with Immunity, Inflammation, and Cytokines. Cardiovascular Therapeutics 2021, pages 1-18.
Crossref
Crossref
Eleni Angeloudi, Eleni Pagkopoulou, Alexandra Arvanitaki, Stergios Soulaidopoulos, Alexandros Garyfallos, George Kitas & Theodoros Dimitroulas. (2020) Cardiovascular Risk in Systemic Sclerosis. Current Treatment Options in Rheumatology 6:3, pages 282-298.
Crossref
Crossref